about
Biological characterization of highly pathogenic avian influenza H5N1 viruses that infected humans in Egypt in 2014-2015.Re-emergence of amantadine-resistant variants among highly pathogenic avian influenza H5N1 viruses in Egypt.Proteolytic enzymes in embryonated chicken eggs sustain the replication of egg-grown low-pathogenicity avian influenza viruses in cells in the absence of exogenous proteasesMolecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade.Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013.The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in EgyptContinuing threat of influenza (H5N1) virus circulation in Egypt.Serological Evidence of Human Infection with Avian Influenza A H7virus in Egyptian Poultry Growers.Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.Avian Influenza A(H5N1) Virus in EgyptComplete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt.Complete Genome Sequence of the First H5N1 Avian Influenza Virus Isolated from Chickens in Lebanon in 2016.Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt.Active surveillance for avian influenza virus, Egypt, 2010-2012.Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses.Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011.Novel reassortant H9N2 viruses in pigeons and evidence for antigenic diversity of H9N2 viruses isolated from quails in Egypt.Characterization of the recent outbreak of foot-and-mouth disease virus serotype SAT2 in Egypt.Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.Synthesis and screening of some novel fused thiophene and thienopyrimidine derivatives for anti-avian influenza virus (H5N1) activity.Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013-2015.Evidence of infection with avian, human, and swine influenza viruses in pigs in Cairo, Egypt.Efficacy of commercial vaccines against newly emerging avian influenza H5N8 virus in Egypt.Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013Isolation and characterization of a distinct influenza A virus from Egyptian batsMiddle East respiratory syndrome coronavirus infection in non-camelid domestic mammalsEvolution of H5-Type Avian Influenza A Virus Towards Mammalian Tropism in Egypt, 2014 to 2015Comparative Virological and Pathogenic Characteristics of Avian Influenza H5N8 Viruses Detected in Wild Birds and Domestic Poultry in Egypt during the Winter of 2016/2017Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in EgyptCo-infection with different serotypes of FMDV in vaccinated cattle in Southern EgyptA Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c MiceBacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoVDiversity of Astroviruses Circulating in Humans, Bats, and Wild Birds in EgyptCoding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt
P50
Q30395393-B1E2FDC6-3FDD-4C2A-BF2A-ABB71C2B6E4FQ30395536-BBF83488-B504-40DA-92CA-A43E7495C9EAQ33660061-211314AB-7F65-4387-8799-D858CBC1C6A3Q33761804-B25C21C0-AEEC-4743-AC16-59790F4F7A62Q34386091-90B35F10-4CCF-421A-B26B-9ABBADE1E468Q34703972-9531AB2B-9035-48DE-9BA0-02E8DC1BDB7FQ35848998-0B65F88A-6EC3-440A-AE32-53BF2ECE6B45Q36040005-4DDB7546-7607-4CBD-831E-101B60289FFDQ36421986-A5F9A0AE-CA51-493C-ADE8-8F77C242F76FQ36617093-D4D20B2A-CBBC-4054-8771-02998F0DF3A8Q36851367-68B77A7F-2661-45F4-B985-3CCBC665099CQ37355377-A383C99D-EA54-4724-9E16-25660E8284D2Q37617630-7509372A-D34F-4A48-A2A0-BF1D7DD8A40EQ37664608-71DFB258-C1B5-4675-A6B4-9B308F81895EQ37708530-C96E65D9-E1CD-40A2-9983-491259D030DBQ38700137-380D7269-A9F7-41A8-989C-409617C8EBABQ38990038-3285827C-906F-4710-B475-2EEC6F0C93F9Q39118780-1B3123D9-170E-440B-A68A-E4CCBE64ACA8Q39118796-7F269738-E1B9-4AF7-98EB-B9335C22C4CBQ40117421-B4164ECE-C640-4170-AAC8-5A53A54F0819Q41928434-92858CE8-D983-4259-A0E3-BC8EB1EB1B79Q42911928-9F235CB3-0493-4C44-9232-F2B2B8DA2101Q43110277-10DFF401-3A49-4E16-899B-548E02ADC4E6Q47598452-F50F0EF0-48E0-40C2-BA8B-0397947D4F35Q55512200-F860ACCF-9472-45D7-A754-6B29F182DA99Q56226675-4B263D40-007B-4508-A01F-2470DE7C593CQ58089540-A985B765-87C7-41E9-86B9-D37C6DD3E786Q64227237-4EE36DB1-7349-44B0-B86E-B6AEFA6A7845Q91190237-FDC51CD5-AFA0-469A-9D00-EE67CFEF8EEEQ91254360-955CE31C-94BE-45ED-8342-3043BBC1FA3CQ91549708-15740FEE-D8D3-4132-B715-3501554BBD2AQ91638891-9F5E79F9-189B-4847-A871-B59632193688Q91762586-DC95DC4B-A293-4660-815A-B5A23098011FQ92376969-0AEC3800-F3EF-4553-B3F8-6E9B606CC7FFQ94480683-B43F74EA-4116-429E-936A-9DE4ECCA16EAQ95935713-4F164CB0-C1E9-411A-9839-47939B195B07
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ahmed Kandeil
@ast
Ahmed Kandeil
@en
Ahmed Kandeil
@es
Ahmed Kandeil
@nl
type
label
Ahmed Kandeil
@ast
Ahmed Kandeil
@en
Ahmed Kandeil
@es
Ahmed Kandeil
@nl
prefLabel
Ahmed Kandeil
@ast
Ahmed Kandeil
@en
Ahmed Kandeil
@es
Ahmed Kandeil
@nl
P1053
B-3345-2016
P106
P1153
37034258700
P21
P31
P3829
P496
0000-0003-3253-6961